These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Post-transplantation lymphoproliferative disorder after kidney transplantation: report of a nationwide French registry and the development of a new prognostic score. Caillard S, Porcher R, Provot F, Dantal J, Choquet S, Durrbach A, Morelon E, Moal V, Janbon B, Alamartine E, Pouteil Noble C, Morel D, Kamar N, Buchler M, Mamzer MF, Peraldi MN, Hiesse C, Renoult E, Toupance O, Rerolle JP, Delmas S, Lang P, Lebranchu Y, Heng AE, Rebibou JM, Mousson C, Glotz D, Rivalan J, Thierry A, Etienne I, Moal MC, Albano L, Subra JF, Ouali N, Westeel PF, Delahousse M, Genin R, Hurault de Ligny B, Moulin B. J Clin Oncol; 2013 Apr 01; 31(10):1302-9. PubMed ID: 23423742 [Abstract] [Full Text] [Related]
10. Impact of Epstein-Barr virus donor and recipient serostatus on the incidence of post-transplant lymphoproliferative disorder in kidney transplant recipients. Sampaio MS, Cho YW, Shah T, Bunnapradist S, Hutchinson IV. Nephrol Dial Transplant; 2012 Jul 01; 27(7):2971-9. PubMed ID: 22273720 [Abstract] [Full Text] [Related]
11. Incidence, Risk Factors, Clinical Management, and Outcomes of Posttransplant Lymphoproliferative Disorder in Kidney Transplant Recipients. Liu M, Husain S, Famure O, Li Y, Kim SJ. Prog Transplant; 2019 Jun 01; 29(2):185-193. PubMed ID: 30845885 [Abstract] [Full Text] [Related]
15. Posttransplant lymphoproliferative disorder in pancreas transplantation: a single-center experience. Paraskevas S, Coad JE, Gruessner A, Kandaswamy R, Humar A, Sutherland DE, Gruessner RW. Transplantation; 2005 Sep 15; 80(5):613-22. PubMed ID: 16177635 [Abstract] [Full Text] [Related]
16. Early onset post-transplant lymphoproliferative disease is associated with allograft localization. Bakker NA, van Imhoff GW, Verschuuren EA, van Son WJ, Homan van der Heide JJ, Veeger NJ, Kluin PM, Kluin-Nelemans HC. Clin Transplant; 2005 Jun 15; 19(3):327-34. PubMed ID: 15877793 [Abstract] [Full Text] [Related]
17. Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States. Quinlan SC, Pfeiffer RM, Morton LM, Engels EA. Am J Hematol; 2011 Feb 15; 86(2):206-9. PubMed ID: 21264909 [Abstract] [Full Text] [Related]
20. Low 5-year cumulative incidence of post-transplant lymphoproliferative disorders after solid organ transplantation in Switzerland. Steiner R, Kridel R, Giostra E, McKee T, Achermann R, Mueller N, Manuel O, Dickenmann M, Schuurmans MM, de Leval L, Fehr T, Tinguely M, Binet I, Cogliatti S, Haralamvieva E, Koller M, The Swiss Transplant Cohort Study Stcs, Dietrich PY. Swiss Med Wkly; 2018 Apr 15; 148():w14596. PubMed ID: 29518251 [Abstract] [Full Text] [Related] Page: [Next] [New Search]